At the time of writing, Merck & Co Inc [MRK] stock is trading at $97.76, up 2.94%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MRK shares have gain 5.21% over the last week, with a monthly amount glided 12.14%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Merck & Co Inc [NYSE: MRK] stock has seen the most recent analyst activity on November 13, 2025, when Scotiabank initiated its Sector Outperform rating and assigned the stock a price target of $105. On September 17, 2025, downgrade downgraded it’s rating to Hold but maintained its price target of $90 on the stock. Citigroup downgraded its rating to a Neutral but stick to its price target of $84 on May 14, 2025. Cantor Fitzgerald initiated its recommendation with a Neutral and recommended $85 as its price target on April 22, 2025. Deutsche Bank downgraded its rating to Hold for this stock on February 18, 2025, and downed its price target to $105. In a note dated February 10, 2025, TD Cowen downgraded a Hold rating on this stock and revised its target price from $121 to $100.
For the past year, the stock price of Merck & Co Inc fluctuated between $73.31 and $105.07. Currently, Wall Street analysts expect the stock to reach $95 within the next 12 months. Merck & Co Inc [NYSE: MRK] shares were valued at $97.76 at the most recent close of the market. An investor can expect a potential drop of -2.82% based on the average MRK price forecast.
Analyzing the MRK fundamentals
According to Merck & Co Inc [NYSE:MRK], the company’s sales were 63.90B for trailing twelve months, which represents an 2.80% jump. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.36%, Pretax Profit Margin comes in at 0.34%, and Net Profit Margin reading is 0.3%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.39 and Total Capital is 0.28. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.8.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 95.32 points at the first support level, and at 92.89 for the second support level. However, for the 1st resistance point, the stock is sitting at 100.23, and for the 2nd resistance point, it is at 102.71.
Ratios To Look Out For
It is important to note that Merck & Co Inc [NYSE:MRK] has a current ratio of 1.66. Further, the Quick Ratio stands at 1.44, while the Cash Ratio is 0.63. Considering the valuation of this stock, the price to sales ratio is 3.80, the price to book ratio is 4.69 and price to earnings (TTM) ratio is 12.93.
Transactions by insiders
Recent insider trading involved Downing Cristal N, Chief Comm. & Public Afrs Ofcr, that happened on Nov 10 ’25 when 7085.0 shares were sold. Officer, CRISTAL DOWNING completed a deal on Nov 10 ’25 to buy 7085.0 shares. Meanwhile, EVP,Chief Info&Digital Officer Williams David Michael sold 8614.0 shares on Nov 03 ’25.
